Syncona (SYNC) News Today GBX 88.20 -1.50 (-1.67%) As of 06:27 AM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlinesBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Syncona (LON:SYNC) Hits New 12-Month Low - Here's What HappenedSyncona (LON:SYNC) Sets New 12-Month Low - Here's What HappenedApril 10, 2025 | marketbeat.comSyncona Limited Executes Share Buyback to Strengthen Market PositionApril 7, 2025 | tipranks.comSyncona (LON:SYNC) Hits New 52-Week Low - Time to Sell?Syncona (LON:SYNC) Reaches New 52-Week Low - What's Next?April 3, 2025 | marketbeat.comSyncona Limited Updates Total Voting Rights for ShareholdersApril 1, 2025 | tipranks.comSyncona (LON:SYNC) Hits New 12-Month Low - Time to Sell?Syncona (LON:SYNC) Reaches New 52-Week Low - Should You Sell?March 28, 2025 | marketbeat.comSyncona Limited Executes Share Buyback ProgramMarch 25, 2025 | tipranks.comSyncona Limited Executes Share Buyback to Strengthen Capital StructureMarch 24, 2025 | tipranks.comSyncona (LON:SYNC) Hits New 52-Week Low - Should You Sell?Syncona (LON:SYNC) Hits New 1-Year Low - Here's WhyMarch 22, 2025 | marketbeat.comSyncona (LON:SYNC) Share Price Passes Below 50-Day Moving Average - What's Next?Syncona (LON:SYNC) Shares Pass Below Fifty Day Moving Average - Here's What HappenedMarch 21, 2025 | marketbeat.comSyncona Limited Executes Share Buyback to Strengthen Market PositionMarch 12, 2025 | tipranks.comSyncona (LON:SYNC) Sets New 52-Week Low - Here's What HappenedSyncona (LON:SYNC) Sets New 12-Month Low - Here's What HappenedMarch 7, 2025 | marketbeat.comSyncona (LON:SYNC) Stock Price Down 1.6% - Time to Sell?Syncona (LON:SYNC) Trading Down 1.6% - Should You Sell?March 7, 2025 | marketbeat.comThe Wellcome Trust Acquires Major Stake in Syncona LimitedMarch 4, 2025 | tipranks.comSyncona Limited Acquires 150,000 Shares Under Buyback ProgramFebruary 21, 2025 | tipranks.comSyncona Limited Executes Share Buyback to Enhance Shareholder ValueFebruary 19, 2025 | tipranks.comSyncona (LON:SYNC) Hits New 12-Month Low - Here's WhySyncona (LON:SYNC) Sets New 1-Year Low - Time to Sell?February 12, 2025 | marketbeat.comSyncona Executes Share Buyback to Optimize Capital StructureFebruary 11, 2025 | tipranks.comSyncona Limited Enhances Capital Structure with Share BuybackFebruary 10, 2025 | tipranks.comSyncona Limited Executes Share Buyback to Strengthen Capital StructureFebruary 7, 2025 | tipranks.comSyncona sees negative nine-month return despite quarterly riseFebruary 6, 2025 | lse.co.ukSyncona investee Achilles plans liquidation and capital returnFebruary 6, 2025 | lse.co.ukSyncona Limited Executes Share Buyback, Impacting Voting RightsFebruary 5, 2025 | tipranks.comSyncona (LON:SYNC) Sets New 52-Week Low - Should You Sell?Syncona (LON:SYNC) Sets New 1-Year Low - Should You Sell?February 4, 2025 | marketbeat.comSyncona Share Chat (SYNC)February 4, 2025 | lse.co.ukSyncona’s Spur Therapeutics Reports Promising Gene Therapy Data in Gaucher Disease TrialFebruary 4, 2025 | tipranks.comSyncona Executes Strategic Share BuybackFebruary 4, 2025 | tipranks.comSyncona Limited Announces Total Voting RightsFebruary 3, 2025 | tipranks.comSyncona Limited Expands Share Buyback ProgrammeJanuary 31, 2025 | tipranks.comSyncona (LON:SYNC) Trading 0.4% Higher - Time to Buy?Syncona (LON:SYNC) Shares Up 0.4% - Still a Buy?January 29, 2025 | marketbeat.comSyncona Limited Executes Share Buyback to Enhance Capital ManagementJanuary 27, 2025 | tipranks.com‘I oversaw the largest investment trust merger in British history – but I missed Nvidia’January 14, 2025 | finance.yahoo.comSyncona (LON:SYNC) Hits New 1-Year Low - Here's What HappenedSyncona (LON:SYNC) Reaches New 1-Year Low - Here's WhyJanuary 7, 2025 | marketbeat.comSyncona (LON:SYNC) Trading Down 2.1% - What's Next?Syncona (LON:SYNC) Shares Down 2.1% - Should You Sell?January 3, 2025 | marketbeat.comSyncona Limited Reports Total Voting Rights for Year-End 2024January 2, 2025 | tipranks.comSyncona Enhances Shareholder Value with Share BuybackDecember 31, 2024 | tipranks.comSyncona: Achilles Announces Sale Of Technology Assets To AstraZeneca - Quick FactsDecember 27, 2024 | markets.businessinsider.comSyncona Limited Updates on Share Buyback ProgramDecember 27, 2024 | tipranks.comAchilles Therapeutics Sells Key Assets to AstraZenecaDecember 27, 2024 | tipranks.comSyncona (LON:SYNC) Stock Price Up 0.4% - Time to Buy?Syncona (LON:SYNC) Stock Price Up 0.4% - Here's What HappenedDecember 12, 2024 | marketbeat.comSyncona’s iOnctura Reports Positive Phase I Results for Roginolisib in Uveal MelanomaDecember 11, 2024 | tipranks.comSyncona Limited Executes Share Buyback as Part of Capital Management StrategyDecember 11, 2024 | tipranks.comSyncona Limited Strengthens Position with Share BuybackDecember 9, 2024 | msn.comSyncona hails positive trial data for new Beacon Therapeutics drugDecember 6, 2024 | lse.co.ukSyncona’s Beacon Reports Promising Trial ResultsDecember 6, 2024 | tipranks.comSyncona Limited Updates on Voting Rights and StrategyDecember 2, 2024 | tipranks.comSyncona Shs GBP Announces Board Committee UpdateNovember 19, 2024 | msn.comSyncona net assets values down; announces new portfolio firm SlingshotNovember 15, 2024 | lse.co.ukSyncona's Autolus wins FDA approval for aggressive leukaemia therapyNovember 12, 2024 | lse.co.ukSyncona’s Autolus Gains FDA Approval for Leukemia TherapyNovember 12, 2024 | msn.comSyncona : Autolus Receives FDA Approval For AUCATZYL In Adults With Relapsed/Refractory B-ALLNovember 12, 2024 | markets.businessinsider.com Remove Ads Get Syncona News Delivered to You Automatically Sign up to receive the latest news and ratings for SYNC and its competitors with MarketBeat's FREE daily newsletter. Email Address SYNC Media Mentions By Week SYNC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SYNC News Sentiment▼-0.990.64▲Average Financial Services News Sentiment SYNC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SYNC Articles This Week▼11▲SYNC Articles Average Week Remove Ads Get Syncona News Delivered to You Automatically Sign up to receive the latest news and ratings for SYNC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MNKS News Today BPT News Today TRIG News Today BHMG News Today CLDN News Today QLT News Today SSON News Today WTAN News Today TEM News Today JAM News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:SYNC) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredRadical shift coming to the stock market (read this ASAP)This is an urgent warning for all American investors … In a matter of days, we could see a radical shift in...Weiss Ratings | SponsoredFirst look: The $3,500 iPhoneDid you hear that just before Trump's tariffs took effect, Apple sent five cargo planes packed with MacBooks a...Stansberry Research | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMusk's panic move: What the world's richest man fears is comingWhether you have modest savings of $10,000 or substantial wealth of $10 million, this information could determ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syncona Please log in to your account or sign up in order to add this asset to your watchlist. Share Syncona With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
